Zevra Therapeutics, Inc. (ZVRA)

8.28 -0.21 (-2.47%) USD  |  NASDAQ  |  Jan 12, 11:15
More

Zevra Therapeutics Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for ZVRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
XOMA Royalty Corp. Upgrade
Verastem, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Akebia Therapeutics, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade